EUVIMEDEUVIMED entdecken
Crossref

PRO: Patients With Metastatic/Recurrent Cervical Cancer Should be Treated With Cisplatin Plus Paclitaxel

Krishnansu S. Tewari

Clinical Ovarian Cancer · 2011

DOI: 10.1016/j.cloc.2012.02.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von Krishnansu S. Tewari. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tewari, K. S. (2011). PRO: Patients With Metastatic/Recurrent Cervical Cancer Should be Treated With Cisplatin Plus Paclitaxel. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2012.02.014

Vancouver

Tewari KS. PRO: Patients With Metastatic/Recurrent Cervical Cancer Should be Treated With Cisplatin Plus Paclitaxel. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2012.02.014

BibTeX
@article{Tewari2011,
  author = {Tewari, Krishnansu S.},
  title = {PRO: Patients With Metastatic/Recurrent Cervical Cancer Should be Treated With Cisplatin Plus Paclitaxel},
  journal = {Clinical Ovarian Cancer},
  year = {2011},
  doi = {10.1016/j.cloc.2012.02.014}
}
Kostenlos starten →